Literature DB >> 11284798

Health-related quality of life assessment in young adults with seasonal allergic rhinitis.

G Majani1, I Baiardini, A Giardini, G E Senna, P Minale, S D'Ulisse, G Ciprandi, G W Canonica.   

Abstract

BACKGROUND: In health-related quality of life (HRQL) studies on allergic rhinitis, both disease-specific and generic questionnaires have been extensively used. Seasonal allergic rhinitis (SAR) has been studied mainly by focusing on symptomatology. The present study aimed to evaluate the SAR-HRQL by means of two questionnaires, the Medical Outcome Study Short Form Health Survey (SF-36) and a new instrument examining satisfaction in 32 aspects of daily life: the Satisfaction Profile (SAT-P).
METHODS: Thirty-three patients with SAR (aged 33.5+/-8.5 years; 12 men, 21 women) were evaluated during and 2 months after the pollen season. Data were compared with reference samples by t-test, and baseline and follow-up HRQL scores were compared by a matched-pair test.
RESULTS: Patients' HRQL scores collected during the pollen season were significantly lower than reference sample data in many SF-36 scores and in one SAT-P item. No differences emerged between SF-36 and SAT-P scores collected outside the pollen season and reference sample scores. Compared to baseline, outside the pollen season, patients reported significantly higher scores in the following SF-36 scales: physical functioning (P=0.002), physical role (P=0.00001), bodily pain (P=0.01), and vitality (P=0.008); and significantly higher scores in only two SAT-P items (physical well-being [P=0.009] and resistance to stress [P=0.01]).
CONCLUSIONS: Our data confirm the utility of using symptomatologic and health-status questionnaires in evaluating the HRQL of SAR patients. More general quality of life questionnaires may prevent the symptomatologic and functional problems from being adequately recognized and managed. SAT-P can be a fruitful additional tool in HRQL evaluation.

Entities:  

Mesh:

Year:  2001        PMID: 11284798     DOI: 10.1034/j.1398-9995.2001.00852.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  8 in total

1.  International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Authors:  Sarah K Wise; Sandra Y Lin; Elina Toskala; Richard R Orlandi; Cezmi A Akdis; Jeremiah A Alt; Antoine Azar; Fuad M Baroody; Claus Bachert; G Walter Canonica; Thomas Chacko; Cemal Cingi; Giorgio Ciprandi; Jacquelynne Corey; Linda S Cox; Peter Socrates Creticos; Adnan Custovic; Cecelia Damask; Adam DeConde; John M DelGaudio; Charles S Ebert; Jean Anderson Eloy; Carrie E Flanagan; Wytske J Fokkens; Christine Franzese; Jan Gosepath; Ashleigh Halderman; Robert G Hamilton; Hans Jürgen Hoffman; Jens M Hohlfeld; Steven M Houser; Peter H Hwang; Cristoforo Incorvaia; Deborah Jarvis; Ayesha N Khalid; Maritta Kilpeläinen; Todd T Kingdom; Helene Krouse; Desiree Larenas-Linnemann; Adrienne M Laury; Stella E Lee; Joshua M Levy; Amber U Luong; Bradley F Marple; Edward D McCoul; K Christopher McMains; Erik Melén; James W Mims; Gianna Moscato; Joaquim Mullol; Harold S Nelson; Monica Patadia; Ruby Pawankar; Oliver Pfaar; Michael P Platt; William Reisacher; Carmen Rondón; Luke Rudmik; Matthew Ryan; Joaquin Sastre; Rodney J Schlosser; Russell A Settipane; Hemant P Sharma; Aziz Sheikh; Timothy L Smith; Pongsakorn Tantilipikorn; Jody R Tversky; Maria C Veling; De Yun Wang; Marit Westman; Magnus Wickman; Mark Zacharek
Journal:  Int Forum Allergy Rhinol       Date:  2018-02       Impact factor: 3.858

2.  [The association between allergic rhinitis control and sleep quality].

Authors:  R A Gaudin; L P Hoehle; M-A Birkelbach; K M Phillips; A G Beule; D S Caradonna; S T Gray; A R Sedaghat
Journal:  HNO       Date:  2017-12       Impact factor: 1.284

3.  Symptoms treatment for allergic rhinitis using diode laser: results after 6-year follow-up.

Authors:  Yao-Lung Tsai; Chin-Chuan Su; Hong-Shen Lee; Hui-Chuan Chen; Mu-Kuan Chen
Journal:  Lasers Med Sci       Date:  2008-04-17       Impact factor: 3.161

4.  Once-daily sublingual allergen-specific immunotherapy improves quality of life in patients with grass pollen-induced allergic rhinoconjunctivitis: a double-blind, randomised study.

Authors:  Sabina Rak; William H Yang; Martin R Pedersen; Stephen R Durham
Journal:  Qual Life Res       Date:  2006-10-11       Impact factor: 3.440

5.  Subjective impact of osteoarthritis flare-ups on patients' quality of life.

Authors:  Giuseppina Majani; Anna Giardini; Aurelio Scotti
Journal:  Health Qual Life Outcomes       Date:  2005-03-16       Impact factor: 3.186

6.  Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen immunotherapy.

Authors:  Chris D Poole; Christian A Bannister; Jakob Nørgaard Andreasen; Jens Strodl Andersen; Craig J Currie
Journal:  Health Qual Life Outcomes       Date:  2014-06-13       Impact factor: 3.186

Review 7.  Burden of allergic respiratory disease: a systematic review.

Authors:  A Linneberg; K Dam Petersen; J Hahn-Pedersen; E Hammerby; N Serup-Hansen; N Boxall
Journal:  Clin Mol Allergy       Date:  2016-09-28

8.  An observational cohort study of the use of five-grass-pollen extract sublingual immunotherapy during the 2015 pollen season in France.

Authors:  Patrick Blin; Pascal Demoly; Martine Drouet; Bruno Falissard; Séverine Lignot-Maleyran; Hélène Maizi; Simon Lorrain; Régis Lassalle; Cécile Droz-Perroteau; Nicholas Moore; Mathieu Molimard
Journal:  Allergy Asthma Clin Immunol       Date:  2018-09-24       Impact factor: 3.406

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.